Concentric Analgesics Announces Poster Presentation of Positive Vocacapsaicin Data from Total Knee Arthroplasty Phase 2 Study at the 2021 American Academy of Hip and Knee Surgeons Annual Meeting

SAN FRANCISCO--(BUSINESS WIRE)--Concentric Analgesics, Inc. today announced the poster presentation of clinical data for vocacapsaicin, its first-in-class non-opioid lead product candidate for the management of postsurgical pain, at the 2021 American Academy of Hip and Knee Surgeons (“AAHKS”) Annual Meeting in November in Dallas, Texas. This was the first scientific...

Click to view original post